Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Self-Study Modules - Continuing Education Activities

Self-Study Modules on Tuberculosis 1 - 5

PROGRAM DESCRIPTION: The Self-Study Modules on Tuberculosis, 1-5 includes a set of five educational modules, an introduction, and a glossary designed to provide education about various topics on tuberculosis (TB) through a self-study format.

Activity Number
Activity Title/Topic

WB2556
Self Study on Tuberculosis (Modules 1-5)

Origination Date: 

April 25, 2016

Expiration Date: 

April 25, 2018

Location

http://www.cdc.gov/tb/education/ssmodules/default.htm

Hardware/Software

Computer; Internet connection

Materials

Participants will need a print version of the Self-Study Modules on Tuberculosis, 1-5 or a computer with an internet connection to access the online version of the Modules at www.cdc.gov/tb/education/ssmodules/default.htm.

Target Audience:

The target audience for this course is health care workers such as outreach workers, nurses, physicians, administrators, and students from a variety of settings, including: TB programs, managed care organizations, homeless shelters, migrant clinics, substance abuse facilities, nursing and medical schools, and other facilities serving persons with or at risk for TB.

Prerequisites

None. The target audience for this course is entry- level public health workers who have little or no background in tuberculosis.

Format

Enduring Material

Objectives

After completing The Self-Study Modules on Tuberculosis, 1-5 participants will be able to:

Module 1: Transmission and Pathogenesis of Tuberculosis

  1. Describe the history of TB.
  2. Explain how TB is spread (transmission).
  3. Define drug-resistant TB.
  4. Explain the difference between LTBI and TB disease.
  5. Explain how LTBI and TB disease develop (pathogenesis).
  6. Describe the classification system for TB.

Module 2: Epidemiology of Tuberculosis

  1. Describe how the number of TB cases reported in the United States has changed over the last 60 years.
  2. List five factors that contributed to the increase in the number of TB cases between 1985 and 1992.
  3. List three improvements TB programs were able to make with increased federal, state, and other funds and resources that have contributed to a decrease in TB cases since 1993.
  4. List the groups of people who are more likely to be exposed to or infected with M. tuberculosis.
  5. List the groups of people who are more likely to develop TB disease once infected with M. tuberculosis.

Module 3: Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease

  1. Identify high-risk groups for targeted testing.
  2. Describe how to place, read, and interpret a Mantoux tuberculin skin test.
  3. Describe how to interpret an interferon-gamma release assay.
  4. Discuss considerations for using either the Mantoux tuberculin skin test or an interferon-gamma release assay for diagnosing latent tuberculosis infection.
  5. Describe the components of a medical evaluation for diagnosing TB disease.

Module 4: Treatment of Tuberculosis Infection and Disease

  1. List the groups of people who should receive high priority for LTBI treatment.
  2. Describe treatment regimens for LTBI.
  3. Describe treatment regimens for TB disease.
  4. Describe the principles of preventing drug resistance.
  5. Describe patient monitoring during LTBI and TB disease treatment.
  6. Describe TB treatment adherence strategies.
  7. List the common adverse reactions to the drugs used to treat LTBI and TB disease.

Module 5: Infectiousness and Infection Control

  1. Describe the factors that determine the infectiousness of a TB patient.
  2. Describe the main goals of a TB infection-control program.
  3. Describe the three levels of control measures that are the basis of an effective infection-control program.
  4. Describe the purpose and the characteristics of a TB airborne infection isolation room.
  5. Describe the circumstances when personal respirators should be used.

Contact Information

Division of Tuberculosis Elimination
http://wwwn.cdc.gov/dcs/RequestForm.aspx 

Accreditation Statements

CME:  The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE:  The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 5.1 contact hours.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer 0.5 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 5.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

DISCLOSURE:

In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. 

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.

To receive continuing education (CE):

You may participate in the educational activity by viewing the program information above.

To receive continuing education, you must register for this specific course and submit an evaluation and posttest at the CDC Training and Continuing Education Online website.

  • Go to www2a.cdc.gov/TCEonline
  • Log in as a participant. (Note: If you are a first-time user of this online system, you will need to log in as a new participant and create a participant profile.)
    • When you receive your reset password by e-mail, log in as a participant and change the password.
  • At Participant Services, click on Search and Register, type a keyword from the course title into the keyword search, such as “TB,” and click View. You can also find the course by typing in the course number. The course number for this activity is WB2556.
  • Click on the title, Self-Study Modules on Tuberculosis, 1-5, select the type of credit/contact hours you wish to receive at the bottom, and click Submit.
  • Verify the demographic information and click Submit at the bottom.
  • Complete the course evaluation.
  • Complete the course posttest (must score 70% or higher to receive CE).
  • At Participant Services, click on Certificates and Transcripts and print your continuing education certificate.

For assistance with the online system, call 1(800)-41-TRAIN Monday through Friday from 8:00 AM to 4:00 PM Eastern Standard Time, or e-mail ce@cdc.gov.

Fees

No fees are charged for CDC’s CE activities.

Top